Archives

img-01

China IVD and Medical Device Update

In mid-May, the Chinese NMPA issued a new IVD Reagent Classification Catalogue. The new catalogue has over 25 primary product varieties and over 1,800 secondary varieties. A number of specific reagent sub-categories are further defined including staining solutions, cell culture media, etc. IVD reagent... Read More

img-01

China NMPA Issues Medical Device Sampling Plan

In an effort to improve the quality of medical devices on the Chinese market, the NMPA, led by the National Institutes for Food and Drug Control (NIFDC), will do sampling inspections at various healthcare facilities. Sixty-six product types will be sampled including products... Read More

img-01

China Drug Clinical Trial Update 2024

Chinese patients want more drugs to treat their diseases. With over 1.4 billion Chinese people and with more than 350 million people in China’s middle class, there is enough disposable money to pay for them. To get more drugs approved in China,... Read More

img-01

2024 China Drug Market Access Update

Over the last 5 years, getting drugs registered in China and available for sale has become more efficient, easier, and a lot quicker. However, China drug pricing is still a major concern. Two drug price reduction schemes are outlined below.  First, one... Read More